Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90.

Sci Rep · 2017 · PMC5596021 · PMID 28900199

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The high tumorigenic capacity of sorted EpCAM + cells compared with unsorted cells was confirmed in vivo , although the difference did not reach statistical significance (Supplementary Fig. 2B and C ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.